These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25896475)

  • 1. One year in review 2015: Sjögren's syndrome.
    Luciano N; Valentini V; Calabrò A; Elefante E; Vitale A; Baldini C; Bartoloni E
    Clin Exp Rheumatol; 2015; 33(2):259-71. PubMed ID: 25896475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis of patients with primary Sjögren's syndrome].
    Brito-Zerón P; Ramos-Casals M
    Med Clin (Barc); 2008 Feb; 130(3):109-15. PubMed ID: 18261383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One year in review 2017: primary Sjögren's syndrome.
    Ferro F; Marcucci E; Orlandi M; Baldini C; Bartoloni-Bocci E
    Clin Exp Rheumatol; 2017; 35(2):179-191. PubMed ID: 28337967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
    Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
    Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Sjogren's syndrome and autoimmune cytopenias: a relation often overlooked.
    Khattri S; Barland P
    Bull NYU Hosp Jt Dis; 2012; 70(2):130-2. PubMed ID: 22892005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-centromere antibody-positive Sjögren's syndrome: A distinct clinical subgroup?
    Lee KE; Kang JH; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Lee SS
    Int J Rheum Dis; 2015 Sep; 18(7):776-82. PubMed ID: 26179502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
    Tzioufas AG; Voulgarelis M
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
    Ter Borg EJ; Kelder JC
    Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis in Sjögren's syndrome: evidence, possible mechanisms and knowledge gaps.
    Valim V; Gerdts E; Jonsson R; Ferreira GA; Brokstad KA; Brun JG; Midtbø H; Mydel PM
    Clin Exp Rheumatol; 2016; 34(1):133-42. PubMed ID: 26812164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agranulocytosis and mixed-type autoimmune hemolytic anemia in primary sjögren's syndrome: a case report and review of the literature.
    Qiao L; Chen J; Leng XM; Zhang W; Han B; Zhao Y; Zeng XF
    Int J Rheum Dis; 2016 Dec; 19(12):1351-1353. PubMed ID: 28371438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
    Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Pathogenesis of Sjögren's Syndrome.
    Tian Y; Yang H; Liu N; Li Y; Chen J
    J Immunol Res; 2021; 2021():5928232. PubMed ID: 34660815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs for primary Sjögren's syndrome.
    Gandolfo S; De Vita S
    Expert Opin Emerg Drugs; 2019 Jun; 24(2):121-132. PubMed ID: 31286787
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sjögren's syndrome].
    Seitz M
    Ther Umsch; 2008 May; 65(5):279-82. PubMed ID: 18622932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of histopathological examination of salivary gland biopsies in diagnosis, prognosis and treatment of Sjögren's Syndrome.
    Barone F; Campos J; Bowman S; Fisher BA
    Swiss Med Wkly; 2015; 145():w14168. PubMed ID: 26375728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy).
    Strand V; Talal N
    Bull Rheum Dis; 1979-1980; 30(9):1046-52. PubMed ID: 398729
    [No Abstract]   [Full Text] [Related]  

  • 18. Annular erythema associated with Sjögren's syndrome preceding overlap syndrome of rheumatoid arthritis and polymyositis with anti-PL-12 autoantibodies.
    Sugiura K; Muro Y; Akiyama M
    Acta Derm Venereol; 2014 Jul; 94(4):470-1. PubMed ID: 24322624
    [No Abstract]   [Full Text] [Related]  

  • 19. Classification criteria for Sjogren's syndrome: a critical review.
    Baldini C; Talarico R; Tzioufas AG; Bombardieri S
    J Autoimmun; 2012 Aug; 39(1-2):9-14. PubMed ID: 22209352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjögren's syndrome.
    Yan S; Li M; Wang H; Yang X; Zhao J; Wang Q; Liu Y; Lai J; Tian Z; Song H; Zhao Y; Zeng X
    Int J Rheum Dis; 2018 May; 21(5):1068-1075. PubMed ID: 29624870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.